Clinical relevance of dynamic risk assessment for developing hepatocellular carcinoma during prolonged antiviral therapy

In this study, the authors concluded that the risk of developing hepatocellular carcinoma (HCC) after 5 years of antiviral therapy (AVT) was dependent on age, baseline cirrhosis status, liver stiffness (LS) values at 5 years. The authors proposed CAGE-B and SAGE-B scores based on a change in fibrotic burden after AVT, representing simple and reliable risk scores for HCC prediction beyond year 5 of AVT. In interpreting and applying these results in clinical practice, several issues should be kept in mind.

Source: Journal of Hepatology - March 31, 2020 Category: Gastroenterology Authors: Han Ah Lee, Beom Kyung Kim, Seung Up Kim Tags: Letter to the Editor Source Type: research